On February 28, 2001, the Defendant borrowed US$ 498,800 from the Bank of Korea Co., Ltd.

When the Defendant delayed the repayment of the loan after the repayment of only a part of the above loan, the Bank of Korea filed a lawsuit against the Defendant and concluded that “the Defendant shall pay to the Plaintiff 205,089,357 won and 141,557,091 won with the rate of 19% per annum from February 5, 2004 to the date of full payment.”

(Seoul High Court Decision 2004Da12902 decided May 20, 2004). The above claims were transferred from our bank to the Plaintiff on November 29, 2007, through Korea EF&A Specialized Asset-backed Securitization Co., Ltd. on December 20, 2007, Korea Ef&A Specialized Asset-backed Securitization Co., Ltd. on July 16, 201, and DNA M&C Co., Ltd on October 11, 2013, and the assignment of claims was notified by each transferor of claims.

The Plaintiff filed the instant lawsuit for the interruption of extinctive prescription.

Articles 208(3)1 and 257(1) of the Civil Procedure Act of the applicable provisions of Acts (a judgment without a presentation of a written reply)